EUS-guided submucosal implantation of a radiopaque marker: a simple and effective procedure to facilitate subsequent surgical and radiation therapy

Gastrointestinal Endoscopy

Volumn 67, Issue 7, 2008, Pages 1147-1152

  Magno, Priscilla ^a   Giday, Samuel A ^a   Gabrielson, Kathleen L ^a   Shin, Eun Ji ^a   Clarke, John O ^a   Ko, Chung Wang ^a   Buscaglia, Jonathan M ^a   Jagannath, Sanjay B ^a   Canto, Marcia I ^a   Kantsevoy, Sergey V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TANTALUM;

ANIMAL EXPERIMENT; ARTICLE; AUTOPSY; CANCER SURVIVAL; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS; EUTHANASIA; FLUOROSCOPY; FOLLOW UP; IMPLANT; INJECTION SITE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STOMACH WALL; SWINE;

ANIMALS; ENDOSONOGRAPHY; ESOPHAGUS; FEASIBILITY STUDIES; FLUOROSCOPY; GASTROINTESTINAL NEOPLASMS; MODELS, ANIMAL; RADIOISOTOPES; RADIOTHERAPY, ADJUVANT; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; STOMACH; SURGICAL PROCEDURES, OPERATIVE; SUS SCROFA; TANTALUM; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 44349171157     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2008.02.053     Document Type: Article

References (52)

1. Fusaroli P., and Caletti G. Endoscopic ultrasonography. Endoscopy 35 (2003) 127-135
2. Fusaroli P., Vallar R., Togliani T., et al. Scientific publications in endoscopic ultrasonography: a 20-year global survey of the literature. Endoscopy 34 (2002) 451-456
3. Reddy R.P., Levy M.J., and Wiersema M.J. Endoscopic ultrasound for luminal malignancies. Gastrointest Endosc Clin North Am 15 (2005) 399-429
4. Rosch T., Lorenz R., Zenker K., et al. Local staging and assessment of resectability in carcinoma of the esophagus, stomach, and duodenum by endoscopic ultrasonography. Gastrointest Endosc 38 (1992) 460-467
5. Murata Y., Suzuki S., and Hashimoto H. Endoscopic ultrasonography of the upper gastrointestinal tract. Surg Endosc 2 (1988) 180-183
6. Vilgrain V., Mompoint D., Palazzo L., et al. Staging of esophageal carcinoma: comparison of results with endoscopic sonography and CT. AJR Am J Roentgenol 155 (1990) 277-281
7. Botet J.F., Lightdale C.J., Zauber A.G., et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology 181 (1991) 426-432
8. Botet J.F., Lightdale C.J., Zauber A.G., et al. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology 181 (1991) 419-425
9. Grimm H., Binmoeller K.F., Hamper K., et al. Endosonography for preoperative locoregional staging of esophageal and gastric cancer. Endoscopy 25 (1993) 224-230
10. Vazquez-Sequeiros E., Norton I.D., Clain J.E., et al. Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc 53 (2001) 751-757
11. Askin M.P., Waye J.D., Fiedler L., et al. Tattoo of colonic neoplasms in 113 patients with a new sterile carbon compound. Gastrointest Endosc 56 (2002) 339-342
12. Shaffer R.T., Francis J.M., Carrougher J.G., et al. India ink tattooing in the esophagus. Gastrointest Endosc 47 (1998) 257-260
13. Beretvas R.I., and Ponsky J. Endoscopic marking: an adjunct to laparoscopic gastrointestinal surgery. Surg Endosc 10 (2000) 1202-1203
14. Shatz B.A., Weinstock L.B., Swanson P.E., et al. Long-term safety of India ink tattoos in the colon. Gastrointest Endosc 45 (1997) 153-156
15. Price N., Gottfried M.R., Clary E., et al. Safety and efficacy of India ink and indocyanine green as colonic tattooing agents. Gastrointest Endosc 51 (2000) 438-442
16. Lane K.L., Vallera R., Washington K., et al. Endoscopic tattoo agents in the colon: tissue responses and clinical implications. Am J Surg Pathol 20 (1996) 1266-1270
17. Park S.I., Genta S.R., Romeo D.P., et al. Colonic abscess and focal peritonitis secondary to india ink tattooing of the colon. Gastrointest Endosc 37 (1991) 68-71
18. Del Rio P., and Dell'Abate P. Complication of an endoscopic tattoo. Endoscopy 35 (2003) 638
19. Magno P., Giday S.A., Gabrielson K.L., et al. Endoscopic ultrasound (EUS)-guided implantation of radiopaque marker into mediastinal and celiac lymph nodes is safe and effective. Gastrointest Endosc 66 (2007) 387-392
20. Shami V.M., and Waxman I. Technology insight: current status of endoscopic ultrasonography. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 38-45
21. Black J. Biological performance of tantalum. Clin Mater 16 (1994) 167-173
22. Harling RJ. Biocompatibility of tantalum and tantalum coated material [technical report]. Available from http://www.tantalum-coating.com/images/ScanFull.pdf. Accessed on Aug 17, 2007.
23. Burke G.L. The corrosion of metals in tissues and an introduction to tantalum. Can Med Assoc J 43 (1940) 125-128
24. Teitelbaum G.P., Ortega H.V., Vinitski S., et al. Low-artifact intravascular devices: MR imaging evaluation. Radiology 168 (1988) 713-719
25. Ulrich B., Kisseler B., Davaris P., et al. Experimental demonstration of mediastinal lymph nodes in dogs using tantalum. Thoraxchir Vask Chir 21 (1973) 112-118
26. Dumont A.E., and Martelli A.B. X-ray opacification of hepatic lymph nodes following intravenous injection of tantalum dust. Lymphology 2 (1969) 91-95
27. Dumont A.E., Martelli A.B., and Schinella R.A. The intranodal distribution of lymph-borne particles injected intravenously. Br J Exp Pathol 63 (1982) 479-484
28. Drinker C.K., Field M.E., and Ward H.K. The filtering capacity of lymph nodes. J Exp Med 59 (1934) 393-405
29. Lawson T.L., Margulis A.R., Nadel J.A., et al. Intraperitoneal introduction of tantalum powder: a roentgenographic and pathologic study. Invest Radiol 4 (1969) 293-300
30. Chalkin B., and Minter J. Limb salvage and abductor reattachment using a custom prosthesis with porous tantalum components. J Arthroplasty 20 (2005) 127-130
31. Strecker E.P., Liermann D., Barth K.H., et al. Expandable tubular stents for treatment of arterial occlusive diseases: experimental and clinical results. Work in progress. Radiology 175 (1990) 97-102
32. Sureshbabu W., and Mawalwi O. PET/CT imaging artifacts. J Nucl Med Tech 33 (2005) 156-161
33. Kinahan P.E., Hasegawa B.H., and Bayer T. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. Semin Nucl Med 33 (2003) 166-179
34. Black J. Biological performance of tantalum. Clin Mater 16 (1994) 167-173
35. Matsuno H., Yokoyama A., Watari F., et al. Biocompatibility and osteogenesis of refractory metal implants, titanium, hafnium, niobium, tantalum and rhenium. Biomaterials 22 (2001) 1253-1262
36. Miller A.C., Fuciarelli A.F., Jackson W.E., et al. Urinary and serum mutagenicity studies with rats implanted with depleted uranium or tantalum pellets. Mutagenesis 13 (1998) 643-648
37. Kalinich J.F., Emond C.A., Dalton T.K., et al. Embedded weapons-grade tungsten alloy shrapnel rapidly induces metastatic high-grade rhabdomyosarcomas in F344 rats. Environ Health Perspect 113 (2005) 729-734
38. Schultz DG. FDA preliminary public health notification: recall of Boston Scientific Enteryx Procedure kits and Enteryx Injector Single Packs for treatment of gastroesophageal reflux disease. Available at http://www.fda.gov/cdrh/safety/101405-enteryx.html. Accessed March 21, 2008.
39. Halkin B., and Minter J. Limb salvage and abductor reattachment using a custom prosthesis with porous tantalum components. J Arthroplasty 20 (2005) 127-130
40. Strecker E.P., Liermann D., Barth K.H., et al. Expandable tubular stents for treatment of arterial occlusive diseases: experimental and clinical results. Work in progress. Radiology 175 (1990) 97-102
41. FDA. Premarket notification (510[k]) and premarket approval (PMA). Available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm and http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm. Accessed August 17, 2007.
42. Pfau P.R., Pham H., Ellis R., et al. A novel use of endoscopic clips in the treatment planning for radiation therapy (XRT) of esophageal cancer. J Clin Gastroenterol 39 (2005) 372-375
43. Riepl M., Pietsch A., Klautke G., et al. Endoscopic pretherapeutic clipping for gastrointestinal tumors: a method for exact definition of the target volume. Strahlenther Onkol 176 (2000) 517-523
44. Shin E.J., Ko C.W., Magno P., et al. Comparative study of endoscopic clips duration of attachment at the site of clip application. Gastrointest Endosc 66 (2007) 757-761
45. Chuttani R., Barkun A., Carpenter S., et al. Technology status evaluation report: endoscopic clip application devices. Gastrointest Endosc 63 (2006) 746-750
46. Gandhi S., Iannitti D.A., Mayo-Smith W.W., et al. Technical report: Lipiodol-guided computed tomography for radiofrequency ablation of hepatocellular carcinoma. Clin Radiol 61 (2006) 888-891
47. Kos S., Haueisen H., Lachmund U., et al. Lymphangiography: forgotten tool or rising star in the diagnosis and therapy of postoperative lymphatic vessel leakage. Cardiovasc Intervent Radiol 30 (2007) 968-973
48. Ikeda K., Nomori H., Mori T., et al. Impalpable pulmonary nodules with ground-glass opacity: success for making pathologic sections with preoperative marking by lipiodol. Chest 131 (2007) 502-506
49. Watanabe K., Nomori H., Ohtsuka T., et al. Usefulness and complications of computed tomography-guided lipiodol marking for fluoroscopy-assisted thoracoscopic resection of small pulmonary nodules: experience with 174 nodules. J Thorac Cardiovasc Surg 132 (2006) 320-324
50. Castellino R.A., Bergiron C., and Markovits P. Experience with 659 consecutive lymphograms in children. Cancer 40 (1997) 1097-1101
51. Matsumoto K., Nojiri J., Takase Y., et al. Cerebral lipiodol embolism: a complication of transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 30 (2007) 512-514
52. Wu R.H., Tzeng W.S., and Chang C.M. Iodized oil embolization to brain following transcatheter arterial embolization of liver. J Gastroenterol Hepatol 20 (2005) 1465-1467